Dr. Frank C. Detterbeck has researched and treated patients afflicted with a variety of thoracic diseases, including lung cancer, lung metastases, mesothelioma, esophageal cancer, mediastinal tumors, chest wall tumors, thymoma, Pancoast tumors and sarcoma. His work in these subjects led to the authoring of numerous research-based publications, including more than 150 papers and book chapters. He currently serves as the associate director of the Yale Cancer Center in New Haven, Connecticut.
It is vital for medical professionals to stay up-to-date on the latest technological breakthroughs and treatment options in their fields, and Dr. Detterbeck has done so. He is well versed in various surgery techniques, particularly in the increasingly popular area of minimally invasive surgery. As opposed to open-chest surgery, minimally invasive surgery requires a much smaller incision, thanks to the use of specialized tools and tiny video cameras that allow surgeons to see their actions inside the patients’ body with the least amount of disruption.
Dr. Detterbeck has given invited lectures at conferences and other scientific gatherings around the globe. He has presented on the topic of thymic tumors at the European Society of Thoracic Surgeons Annual Meeting in Krakow, Poland; on minimally invasive surgery at the European Master Class Course for Minimally-Invasive Thoracic Surgery in Paris, France; and on multimodality therapy of lung cancer at the 11th European Conference on General Thoracic Surgery of the European Society of Thoracic Surgeons in Zurich, Switzerland, among others.
Main Speciality: Thoracic Surgery
Other Interests & Specialties: General cardiac/thoracic surgery and lung removal surgery.
Certifications, Awards & Accolades: American Board of Thoracic Surgery Certification in Thoracic and Cardiac Surgery
Education & Experience:
- Residency for General Surgery at Virginia Mason Medical Center
- Fellowship for Thoracic Surgery at University of North Carolina Hospitals
- Medical Degree from Northwestern University Feinberg School of Medicine
Eighth Edition Staging of Thoracic Malignancies: Implications for the Reporting Pathologist. Archives of Pathology & Laboratory Medicine. May 2018;142(5):645-661. doi: 10.5858/arpa.2017-0245-RA
Neoadjuvant Chemotherapy with Gemcitabine-Containing Regimens in Patients with Early Stage Non-Small Cell Lung Cancer (NSCLC). Journal of Thoracic Oncology. Janurary 2008;3:37-45
Invasive Staging of Lung Cancer: ACCP Evidence-Based Clinical Practice Guideline (2nd Edition) Chest. September 2007;132(3 Suppl):202S-220S. doi: 10.1378/chest.07-1362
- Mesothelioma Doctors
- Cancer Centers
- Treatment Near You
- Experimental Treatments
- Alternative Treatments
- Clinical Trials
- Caregiver Resources
- Treatment Costs